163 related articles for article (PubMed ID: 3237843)
1. Hepatic-portal infusion reduces the satiating potency of CCK-8.
Greenberg D; Smith GP
Physiol Behav; 1988; 44(4-5):535-8. PubMed ID: 3237843
[TBL] [Abstract][Full Text] [Related]
2. Infusion of CCK-8 into hepatic-portal vein fails to reduce food intake in rats.
Greenberg D; Smith GP; Gibbs J
Am J Physiol; 1987 May; 252(5 Pt 2):R1015-8. PubMed ID: 3578549
[TBL] [Abstract][Full Text] [Related]
3. Hepatic-portal and cardiac infusion of CCK-8 and glucagon induce different effects on feeding.
Strubbe JH; Wolsink JG; Schutte AM; Balkan B; Prins AJ
Physiol Behav; 1989 Oct; 46(4):643-6. PubMed ID: 2602489
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin and bombesin act independently to decrease food intake in the rat.
Stein LJ; Woods SC
Peptides; 1981; 2(4):431-6. PubMed ID: 6276871
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal injections of nanogram CCK-8 doses inhibit feeding in rats.
Canova A; Geary N
Appetite; 1991 Dec; 17(3):221-7. PubMed ID: 1799284
[TBL] [Abstract][Full Text] [Related]
6. Combined injection potentiates the satiety effects of pancreatic glucagon, cholecystokinin, and bombesin.
Hinton V; Rosofsky M; Granger J; Geary N
Brain Res Bull; 1986 Nov; 17(5):615-9. PubMed ID: 3801925
[TBL] [Abstract][Full Text] [Related]
7. Gut vagal afferents are necessary for the eating-suppressive effect of intraperitoneally administered ginsenoside Rb1 in rats.
Shen L; Wang DQ; Lo CC; Arnold M; Tso P; Woods SC; Liu M
Physiol Behav; 2015 Dec; 152(Pt A):62-7. PubMed ID: 26384952
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of cholecystokinin develop through interaction with duodenal signals.
Cox JE
Behav Brain Res; 1990 Apr; 38(1):35-44. PubMed ID: 2346615
[TBL] [Abstract][Full Text] [Related]
9. Ineffectiveness of cholecystokinin in impairing runway performance.
Cox JE; Brown PT; Toney RJ; Wiebe DJ
Behav Brain Res; 1984 Oct; 14(1):41-50. PubMed ID: 6097286
[TBL] [Abstract][Full Text] [Related]
10. CCK-58 elicits both satiety and satiation in rats while CCK-8 elicits only satiation.
Overduin J; Gibbs J; Cummings DE; Reeve JR
Peptides; 2014 Apr; 54():71-80. PubMed ID: 24468546
[TBL] [Abstract][Full Text] [Related]
11. Cyclic estradiol replacement increases the satiety effect of CCK-8 in ovariectomized rats.
Geary N; Trace D; McEwen B; Smith GP
Physiol Behav; 1994 Aug; 56(2):281-9. PubMed ID: 7938239
[TBL] [Abstract][Full Text] [Related]
12. Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging.
MacIntosh CG; Morley JE; Wishart J; Morris H; Jansen JB; Horowitz M; Chapman IM
J Clin Endocrinol Metab; 2001 Dec; 86(12):5830-7. PubMed ID: 11739447
[TBL] [Abstract][Full Text] [Related]
13. A novel bombesin receptor antagonist selectively blocks the satiety action of peripherally administered bombesin.
Kirkham TC; Walsh CA; Gibbs J; Smith GP; Leban J; McDermed J
Pharmacol Biochem Behav; 1994 Jul; 48(3):809-11. PubMed ID: 7938140
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the satiating potencies of cholecystokinin-33 and cholecystokinin-8.
Melville LD; Smith GP; Gibbs J
Pharmacol Biochem Behav; 1993 May; 45(1):85-7. PubMed ID: 8516377
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects on intake of cholecystokinin-8 and cholecystokinin-33 in rats with hepatic proper or common hepatic branch vagal innervation.
Eisen S; Phillips RJ; Geary N; Baronowsky EA; Powley TL; Smith GP
Am J Physiol Regul Integr Comp Physiol; 2005 Aug; 289(2):R456-R462. PubMed ID: 15831770
[TBL] [Abstract][Full Text] [Related]
16. Proglumide fails to increase food intake after an ingested preload.
Schneider LH; Gibbs J; Smith GP
Peptides; 1986; 7(1):135-40. PubMed ID: 3714531
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal, but not subcutaneous, administration of the sulphated cholecystokinin octapeptide (CCK-8S) inhibits operant and nonoperant food intake in rats: implications for the CCK-satiety hypothesis.
Ebenezer IS
Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):167-71. PubMed ID: 10389118
[TBL] [Abstract][Full Text] [Related]
18. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
Lieverse RJ; Jansen JB; Masclee AA; Rovati LC; Lamers CB
Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin interacts with prefeeding to impair runway performance.
Cox JE
Behav Brain Res; 1986 Jul; 21(1):29-36. PubMed ID: 3741594
[TBL] [Abstract][Full Text] [Related]
20. CCK inhibits real and sham feeding in gastric vagotomized rats.
Le Sauter J; Goldberg B; Geary N
Physiol Behav; 1988; 44(4-5):527-34. PubMed ID: 3237842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
